{
    "nctId": "NCT02942615",
    "briefTitle": "The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.",
    "officialTitle": "A Randomized Multi-center Phase III Study About the Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Neoplasms, Cardiotoxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "cardiac toxicity event free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients willing to participate the research and sign the informed consent file;\n* Patients aged 18-80 years;\n* KPS\u226570;\n* Pathological diagnosis for invasive breast cancer;\n* Patients received anthracycline/paclitaxel based chemotherapy, or herceptin based targeted therapy;\n* No functional heart disease;\n* LVEF\u226550%;\n* Patients received breast conserving surgery;\n* Patients received modified radical mastectomy: T1-2 with N1-3 or T3-4 with any N;\n* Tumor margin negative;\n* No metastases;\n* No other malignant tumor history.\n\nExclusion Criteria:\n\n* Patients with metastases;\n* Tumor margin positive;\n* Patients received modified radical mastectomy with T1-2 and N0;\n* Patients have other malignant tumor;\n* Patients have a history of heart disease;\n* Patients received chest radiotherapy previously;\n* Patients with severe organic and functional disease;\n* Unqualified patients with sufficient reasons;\n* Cannot or no willing to sign the informed consent file;\n* Patients with autoimmune disease;\n* Women with pregnancy, planned pregnancy or lactating.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}